Descripción del título
Asymptomatic atherosclerosi...
Despite recent advances in the diagnosis and treatment of symptomatic atherosclerosis, available traditional screening methods for early detection and treatment of asymptomatic coronary artery disease are grossly insufficient and fail to identify the majority of victims prior to the onset of a life-threatening event. In Asymptomatic Atherosclerosis: Pathophysiology, Detection and Treatment, Dr. Morteza Naghavi and leading authorities from the Society for Heart Attack Prevention and Eradication (SHAPE) present a new paradigm for the screening and primary prevention of asymptomatic atherosclerosis. The text focuses on accurate, yet underutilized, measures of subclinical atherosclerosis, notably coronary artery calcium scanning and carotid intima-media thickness measurement. The authors introduce a comprehensive approach to identifying the vulnerable patients (asymptomatic individuals at risk of a near future adverse event). Additional chapters discuss future directions towards containing the epidemic of atherosclerotic cardiovascular disease using innovative solutions such as preemptive interventional therapies (bioabsorbable stents) for stabilization of vulnerable atherosclerotic plaques, mass unconditional Polypill therapy for population-based risk reduction, and ultimately vaccination strategies to prevent the development of atherosclerosis. Up-to-date and authoritative, Asymptomatic Atherosclerosis: Pathophysiology, Detection, and Treatment is a must-have for any cardiologist or primary care physician who wishes to practice modern preventive cardiology and manage the increasing number of asymptomatic atherosclerotic patients. Outlines more accurate measures of risk (coronary artery calcium and carotid intima-media thickness) than traditional risk factors (total cholesterol, LDL cholesterol, HDL cholesterol) Presents new multipronged strategies to aid in the early detection and treatment of high risk asymptomatic patients
Monografía
monografia Rebiun24463064 https://catalogo.rebiun.org/rebiun/record/Rebiun24463064 m o d cr cn||||||||| 100909s2010 nyuac ob 001 0 eng d GBB082534 bnb 647810628 676695823 900604641 1005788510 1044292126 1056320962 1058117419 1060831707 1074310410 1078067844 1087373130 1100376730 1126532686 9781603271790 1603271791 1282928139 9781282928138 9786612928130 6612928131 9781603271783 1603271783 10.1007/978-1-60327-179-0 doi AU@ 000048654918 DEBSZ 442814992 NZ1 13520971 978-1-60327-178-3 Springer http://www.springerlink.com GW5XE eng pn GW5XE EBLCP CEF OCLCQ COO YDXCP OCLCQ BEDGE OCLCO OCLCQ CUS VAM N$T E7B DEBSZ A7U OCLCF OCLCQ UAB OCLCQ VT2 IOG OCLCO OCLCQ OCLCO OCLCA OCL OCLCO OCLCQ U3W OCLCO AU@ OCLCO OCLCQ OCLCA YOU LEAUB OCLCO W2U CNMTR UKAHL OCLCQ WURST SFB OCLCQ OCLCA MED 010000 bisacsh MJD bicssc 616.136 22 Asymptomatic atherosclerosis pathophysiology, detection, and treatment edited by Morteza Naghavi [New York] Humana Press ©2010 [New York] [New York] Humana Press 1 online resource (xxii, 737 pages) illustrations (some color), portraits 1 online resource (xxii, 737 pages) Text txt rdacontent computer c rdamedia online resource cr rdacarrier text file PDF rda Contemporary cardiology Includes bibliographical references and index From the contents 1. Preventive Cardiology: The SHAPE of the Future -- 2. From Vulnerable Plaque to Vulnerable Patient -- 3. Pathology of Vulnerability Caused by High Risk (Vulnerable) Arteries and Plaques -- 4. Pathophysiology of Vulnerability Caused by Thrombogenic (Vulnerable) Blood -- 5. Vulnerability Caused by Arrhythmogenic Vulnerable Myocardium -- 6. Approach to the Identification of the Vulnerable Patient -- Current Screening Guidelines in Primary Prevention -- Burden of Atherosclerotic Cardiovascular Disease. Risk Factors vs Susceptibility vs Vulnerability. Screening for Silent Disease to Prevent Deadly Disease. Screening for Atherosclerosis vs Screening for Risk Factors of Atherosclerosis. Methods for the Detection of Subclinical Atherosclerotic Cardiovascular Disease -- Risk Factors: 7. History of evolution of cardiovascular risk factors and the predictive value of Traditional Risk Factor-Based Risk Assessment -- 8. Comprehensive Lipid Profiling Beyond LDL -- 9. New Serum Markers of Inflammation and Atherosclerosis -- 10. Genetic Screening and Sudden Cardiac Death -- 11. Genomics and Proteomics: The Role of Contemporary Biomolecular Analysis -- In Advancing the Knowledge of Atherosclerotic Coronary Artery Disease -- 12. Circulating Endothelial Progenitor Cells -- Mechanism and Measurements -- 13. Family History: An index of genetic and environmental predisposition to coronary artery disease -- 14. Integration of Markers of Endothelial Activation in Mechanism-based Management of Coronary Artery Disease -- Non Invasive, Non Imaging, Assessment of Atherosclerotic Cardiovascular Disease (ACVD) Despite recent advances in the diagnosis and treatment of symptomatic atherosclerosis, available traditional screening methods for early detection and treatment of asymptomatic coronary artery disease are grossly insufficient and fail to identify the majority of victims prior to the onset of a life-threatening event. In Asymptomatic Atherosclerosis: Pathophysiology, Detection and Treatment, Dr. Morteza Naghavi and leading authorities from the Society for Heart Attack Prevention and Eradication (SHAPE) present a new paradigm for the screening and primary prevention of asymptomatic atherosclerosis. The text focuses on accurate, yet underutilized, measures of subclinical atherosclerosis, notably coronary artery calcium scanning and carotid intima-media thickness measurement. The authors introduce a comprehensive approach to identifying the vulnerable patients (asymptomatic individuals at risk of a near future adverse event). Additional chapters discuss future directions towards containing the epidemic of atherosclerotic cardiovascular disease using innovative solutions such as preemptive interventional therapies (bioabsorbable stents) for stabilization of vulnerable atherosclerotic plaques, mass unconditional Polypill therapy for population-based risk reduction, and ultimately vaccination strategies to prevent the development of atherosclerosis. Up-to-date and authoritative, Asymptomatic Atherosclerosis: Pathophysiology, Detection, and Treatment is a must-have for any cardiologist or primary care physician who wishes to practice modern preventive cardiology and manage the increasing number of asymptomatic atherosclerotic patients. Outlines more accurate measures of risk (coronary artery calcium and carotid intima-media thickness) than traditional risk factors (total cholesterol, LDL cholesterol, HDL cholesterol) Presents new multipronged strategies to aid in the early detection and treatment of high risk asymptomatic patients English Atherosclerosis Arteriosclerosis- Diagnosis Arteriosclerosis- Treatment Atherosclerosis- diagnosis Atherosclerosis- physiopathology Atherosclerosis- therapy MEDICAL- Cardiology Médecine Arteriosclerosis- Treatment Atherosclerosis geneeskunde medicine volksgezondheid public health eerstelijnsgezondheidszorg primary health care cardiologie cardiology Medicine (General) Geneeskunde (algemeen) Electronic books Naghavi, Morteza Print version Asymptomatic atherosclerosis. [New York] : Humana Press, ©2010 9781603271783 1603271783 (DLC) 2009930357 (OCoLC)233933570 Contemporary cardiology (Totowa, N.J.)